首页 | 本学科首页   官方微博 | 高级检索  
检索        


Risk of Systemic Adverse Events after Intravitreal Bevacizumab,Ranibizumab, and Aflibercept in Routine Clinical Practice
Authors:Maya H Maloney  Stephanie R Payne  Jeph Herrin  Lindsey R Sangaralingham  Nilay D Shah  Andrew J Barkmeier
Institution:1. Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota;2. Department of Ophthalmology, Kaiser Permanente, Vacaville, California;3. Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota;4. Yale School of Medicine, Yale University, New Haven, Connecticut;5. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota;6. Division of Health Care Policy and Research, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota;7. OptumLabs, Cambridge, Massachusetts
Abstract:
Keywords:anti-VEGF  aflibercept  ranibizumab  bevacizumab  age-related macular degeneration  diabetic retinopathy  retinal vein occlusion  CI"}  {"#name":"keyword"  "$":{"id":"kwrd0055"}  "$$":[{"#name":"text"  "_":"confidence interval  CVD"}  {"#name":"keyword"  "$":{"id":"kwrd0065"}  "$$":[{"#name":"text"  "_":"cerebrovascular disease  DME"}  {"#name":"keyword"  "$":{"id":"kwrd0075"}  "$$":[{"#name":"text"  "_":"diabetic macular edema  DRD"}  {"#name":"keyword"  "$":{"id":"kwrd0085"}  "$$":[{"#name":"text"  "_":"diabetic retinal disease  FDA"}  {"#name":"keyword"  "$":{"id":"kwrd0095"}  "$$":[{"#name":"text"  "_":"Food and Drug Administration  HR"}  {"#name":"keyword"  "$":{"id":"kwrd0105"}  "$$":[{"#name":"text"  "_":"hazard ratio  ICD-9"}  {"#name":"keyword"  "$":{"id":"kwrd0115"}  "$$":[{"#name":"text"  "_":"International Classification of Diseases 9th Revision  ICD-10"}  {"#name":"keyword"  "$":{"id":"kwrd0125"}  "$$":[{"#name":"text"  "_":"International Classification of Diseases 10th Revision  IQR"}  {"#name":"keyword"  "$":{"id":"kwrd0135"}  "$$":[{"#name":"text"  "_":"interquartile range  MI"}  {"#name":"keyword"  "$":{"id":"kwrd0145"}  "$$":[{"#name":"text"  "_":"myocardial infarction  nAMD"}  {"#name":"keyword"  "$":{"id":"kwrd0155"}  "$$":[{"#name":"text"  "_":"neovascular age-related macular degeneration  RVO"}  {"#name":"keyword"  "$":{"id":"kwrd0165"}  "$$":[{"#name":"text"  "_":"retinal vein occlusion  SAE"}  {"#name":"keyword"  "$":{"id":"kwrd0175"}  "$$":[{"#name":"text"  "_":"systemic adverse event  VEGF"}  {"#name":"keyword"  "$":{"id":"kwrd0185"}  "$$":[{"#name":"text"  "_":"vascular endothelial growth factor
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号